SilkTech’s head of R&D, Dr. David Infanger, will be presenting new research at ARVO 2019 in Vancouver, BC.

Please join SilkTech Biopharmaceutical’s Dr. David Infanger, Vice President, R&D, as he presents recent research in characterizing the biologic drug candidate SDP-4 at ARVO (Vancouver, BC) at the “Dry Eye II” papers session on Tuesday, April 30, 2019 from 9:45am to 10:00am in room West 211.

More Information.

Leave a Comment